Drugs / Cultured Red Blood Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00929266 | May 2010 → Nov 2011 | — | Etablissement Français du Sang | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cultured Red Blood Cells | “First Pilot Study Evaluating the Life Span of Autologous Cultured Red Blood Cells (cRBC) Generated From Peripheral Stem Cells in Three Healthy Volunteers - Feasibility Study” NCT00929266 ↗ |
| Known as | cRBC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00929266 ↗ |
| Modality | Cell therapy | “Autologous Cultured Red Blood Cells (cRBC) Generated From Peripheral Stem Cells” NCT00929266 ↗ |
| Route | Intravenous | “Direct intravenous injection of labeled cRBC in a volume of 1 mL” NCT00929266 ↗ |